Back to Search Start Over

Why All the ImClone Interest? Its Pipeline; Big Pharma, hungry to fill thinning sales kits with better-protected oncology drugs, is circling Carl Icahn's hot property

Authors :
Arnst, Catherine
Source :
Business Week Online. Oct 6, 2008
Publication Year :
2008

Subjects

Subjects :
Erbitux (Medication) -- Product information
Diagnostic reagents industry -- Product information
Diagnostic reagents industry -- Securities
Stocks -- Prices and rates
Company securities
Company pricing policy
ImClone Systems Inc. -- Product information
ImClone Systems Inc. -- Securities

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Week Online
Publication Type :
Periodical
Accession number :
edsgcl.186397662

Tools

Authors Abstract Subjects Details